TY - BOOK ID - 8136160 TI - Genetic Influences on Response to Drug Treatment for Major Psychiatric Disorders AU - Rybakowski, Janusz K. AU - Serretti, Alessandro. PY - 2016 SN - 3319270389 3319270400 PB - Cham : Springer International Publishing : Imprint: Adis, DB - UniCat KW - Pharmacy, Therapeutics, & Pharmacology KW - Health & Biological Sciences KW - Antipsychotic drugs. KW - Psychiatry KW - Nature and nurture. KW - Genetics. KW - Alternative treatment. KW - Environment KW - Genetics and environment KW - Heredity and environment KW - Nature KW - Nature versus nurture KW - Nurture and nature KW - Antipsychotic agents KW - Antipsychotics KW - Major tranquilizers KW - Major tranquilizing agents KW - Major tranquilizing drugs KW - Neuroleptic agents KW - Neuroleptic drugs KW - Neuroleptics KW - Neurolepts KW - Tranquilizing drugs, Major KW - Nurture KW - Biology KW - Embryology KW - Mendel's law KW - Adaptation (Biology) KW - Breeding KW - Chromosomes KW - Heredity KW - Mutation (Biology) KW - Variation (Biology) KW - Genetics KW - Human beings KW - Medicine and psychology KW - Mental health KW - Psychology, Pathological KW - Psychotropic drugs KW - Psychoses KW - Effect of environment on KW - Chemotherapy KW - Psychopharmacology. KW - Human genetics. KW - Human Genetics. KW - Heredity, Human KW - Human biology KW - Physical anthropology KW - Behavioral pharmacology KW - Drugs KW - Pharmacology KW - Psychotropic effects UR - https://www.unicat.be/uniCat?func=search&query=sysid:8136160 AB - Written by global experts, this book provides a modern comprehensive insight into the pharmacogenetics of treatment of major psychoses: schizophrenia, bipolar disorder and depression. The pharmacogenomics of three categories of the most important psychiatric drugs, antipsychotics, antidepressants and mood stabilizers, has been updated and reviewed. Some promising directions and perspectives for future research in pharmacogenetics in major psychoses are indicated. They are, among others, connected with the development of new methods in molecular genetics and with linking pharmacogenetics assessment with biomarkers, including neuroimaging ones. Finally, the attempts to use pharmacogenetics of antipsychotic, antidepressant and mood-stabilizing drugs in practice are presented. New pharmacogenetic tools may greatly contribute to introducing personalized medicine into psychiatric clinical practice. ER -